1. < Autoimmune Diseases

VYVGART Hytrulo, a new treatment for CIDP

Posted by kgitti @kgitti, Jul 19 12:18pm

I just came from my neurologist and learned about VYVGART Hytrulo. It is a newly approved immuno suppressant option for chronic inflammatory demyelinating polyneuropathy (CIDP). https://vyvgart.com/vyvgarthytrulo-cidp
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-chronic-inflammatory-demyelinating-polyneuropathy-cidp-adults
She said it will be really expensive and a battle to get my insurance to pay for it but it looks promising. My insurance pays for SCIG Hyzentra 100% thanks to her. So maybe she can pull it off.

Interested in more discussions like this? Go to the Autoimmune Diseases Support Group.

doomy | @doomy | Jul 25 3:02am

Hi,

Yeah I asked about it they said its very expensive However,
Can you share with us whats the advantages of it in compare to retuxan ?and did it really will help ?

Did the neurologist explain any further information because I notice little data except the website of the treatment page .

Hopfully the insurance can cover it in near future

REPLY
kgitti | @kgitti | Jul 30 11:59am

Sorry all I know is what I posted.
My Dr.s’ reading of the studies suggests to her that it may be the best drug currently available. It’s not an “off label” use of an existing drug but actually targeted for CIDP which is a first.

REPLY
Please sign in or register to post a reply.